NASDAQ · Financial Statements
89bio, Inc. (ETNB) Financial Statements
$14.84
NASDAQ: ETNB
Market Cap $2.20B
Overview Financials Dividend 89bio, Inc. most recently reported annual revenue of $0, net profit of $-367.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2020 2021 2022 2023 2024 Revenue $0 $0 $0 $0 $0 Operating Profit $-49.0M $-90.0M $102.0M $-151.0M $-385.0M Net Profit $-49.0M $-90.0M $-102.0M $-142.0M $-367.0M EPS $-3.08 $-4.48 $-2.93 $-2.00 $-3.51 Op Margin — — — — —
Balance Sheet (USD)
Metric 2020 2021 2022 2023 2024 Total Assets $211.0M $162.0M $197.0M $596.0M $479.0M Total Liabilities $8.0M $36.0M $45.0M $60.0M $78.0M Cash $98.0M $52.0M $55.0M $316.0M $126.0M Borrowings $0 $19.0M $21.0M $27.0M $38.0M
Cash Flow (USD)
Metric 2020 2021 2022 2023 2024 Operating Cash Flow $-46.0M $-77.0M $-81.0M $-129.0M $-368.0M Investing Cash Flow $-107.0M $7.0M $-34.0M $-246.0M $-82.0M Financing Cash Flow $0 $0 $1.0M $14.0M $52.0M Net Cash Flow $5.0M $-46.0M $3.0M $261.0M $-190.0M Free Cash Flow $-46.0M $-77.0M $-81.0M $-129.0M $-368.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.22 EV / EBITDA -11.59 FCF Yield -7.83% Quick Ratio 15.19 Interest Coverage -79.76 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock